Targeting the interleukin-15 system in rheumatoid arthritis

Arthritis and Rheumatism

Volumn 52, Issue 9, 2005, Pages 2585-2588

  Waldmann, Thomas A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; MONOCLONAL ANTIBODY;

AUTOIMMUNE DISEASE; CYTOKINE PRODUCTION; EDITORIAL; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PUBLICATION; RHEUMATOID ARTHRITIS;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-15; RECEPTORS, INTERLEUKIN-2;

EID: 25444448198     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.21363     Document Type: Editorial

References (21)

1. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis [review]. Annu Rev Immunol 1996;14:397-440.
2. Baslund B, Tvede N, Danneskiold-Samsoe B, Larsson P, Panayi G, Petersen J, et al. Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study. Arthritis Rheum 2005;52:2686-92.
3. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens [review]. Annu Rev Immunol 1999;17:19-49.
4. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Rα recycles and presents IL-15 in trans to neighboring cells. Immunity 2002;17:537-47.
5. Mariner JM, Lantz V, Waldmann TA, Azimi N. Human T-cell lymphotropic virus type I Tax protein activates interleukin-15Rα gene expression through an NF-κB site. J Immunol 2001;166:2602-9.
6. Lodolce JP, Boone DL, Chai S, Swain RE, Dassopoulos T, Trettin S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998;9:669-76.
7. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease [review]. Blood 2001;97:14-32.
8. Zhang X, Sun S, Hwang I, Tough DF, Sprent J. Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 1998;8:591-9.
9. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 2000;288:675-8.
10. Marks-Konczalik J, Dubois S, Losi JM, Sabzevari H, Yamada N, Feigenbaum L, et al. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci U S A 2000;97:11445-50.
11. Azimi N, Nagai M, Jacobson S, Waldmann TA. IL-15 plays a major role in the persistence of Tax-specific CD8 cells in HAM/TSP patients. Proc Natl Acad Sci U S A 2001;98:14559-64.
12. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 1997;3:189-95.
13. Oppenheimer-Marks N, Brezinschek RI, Mohamadzadeh M, Vita R, Lipsky PE. Interleukin 15 is produced by endothelial cells and increases the transendothelial migration of T cells in vitro and in the SCID mouse-human rheumatoid arthritis model in vivo. J Clin Invest 1998;101:1261-72.
14. McInnes IB, al-Mughales J, Field M, Leung BP, Huang FP, Dixon R, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nat Med 1996;2:175-82.
15. Ruchatz H, Leung BP, Wei XQ, McInnes IB, Liew FY. Soluble IL-15 receptor α-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 1998;160:5654-60.
16. Kim YS, Maslinski W, Zheng XX, Stevens AC, Li XC, Tesch GH, et al. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fcγ2a protein blocks delayed-type hypersensitivity. J Immunol 1998;160:5742-8.
17. Hakimi J, Ha VC, Lin P, Campbell E, Gately MK, Tsudo M, et al. Humanized Mik β 1, a humanized antibody to the IL-2 receptor β-chain that acts synergistically with humanized anti-TAC. J Immunol 1993;151:1075-85.
18. Bamford RN, Grant AJ, Burton JD, Peters C, Kurys G, Goldman CK, et al. The interleukin (IL) 2 receptor âchain is shared by IL-2 and a cytokine, provisionally designated IL-T, that stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A 1994;91:4940-4.
19. Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, et al. Humanized antibody directed to the IL-2 receptor β-chain prolongs primate cardiac allograft survival. J Immunol 1994;153:4330-8.
20. Villadsen LS, Schuurman J, Beurskens F, Dam TN, Dagnaes-Hansen F, Skov L, et al. Resolution of psoriasis upon blockade of IL-15 biological activity in a xenograft mouse model. J Clin Invest 2003;112:1571-80.
21. Kennedy MK, Glaccum M, Brown SN, Butz EA, Viney JL, Embers M, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000;191:771-80.